Implementation of Harmonized Depression Outcome Measures in a Primary Care Registry and a Mental Health Registry
NCT ID: NCT04235725
Last Updated: 2021-05-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
953 participants
OBSERVATIONAL
2020-03-15
2021-05-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Implementation of Harmonized Depression Outcome Measures in a Health System
NCT04235712
Feasibility of Depression Care Management by E-mail
NCT00755235
Symptom Tracking in Assisted Reproductive Technologies
NCT01746797
Augmented Human Intelligence in Major Depressive Disorder
NCT04355650
Digital Interventions for Adults with Treatment-Resistant Depression: a Pilot Study
NCT06732089
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Two registries (PsychPRO and the PRIME Registry) will participate in this feasibility study. A total of 20 sites participating in the registries (10 from each registry) will be recruited to participate in this study. To participate, sites must see adult patients with major depression or dysthymia and be willing to collect the PHQ-9 on a regular basis. Sites will have the option of using the Frequency, Intensity, and Burden of Side Effects Ratings (FIBSER) scale to capture information on adverse events, but use of the FIBSER is not required.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Harmonized Depression Outcome Measures
This is an observational study where retrospective data on previous disease status and patient characteristics will be collected and combined with longitudinal data from these data sources on outcomes during the study timeframe.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of major depression or dysthymia as documented in the patient's EMR
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Agency for Healthcare Research and Quality (AHRQ)
FED
OM1, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
American Psychiatric Association
Washington D.C., District of Columbia, United States
American Board of Family Medicine
Lexington, Kentucky, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
AHRQ webpage containing details on this initiative
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AHRQ_DEP_Registry
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.